Franklin Resources
IMMX icon

Franklin Resources’s Immix Biopharma IMMX Stock Holding History

Franklin Resources’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.83M Sell
969,066
-11,326
-1% -$83.2K ﹤0.01% 1286
2025
Q4 		$5.13M Buy
+980,392
New +$4.03M ﹤0.01% 1392

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Franklin Resources's IMMX Position: Q1 2026 in Review

Franklin Resources reduced its Immix Biopharma (IMMX) stake by 1.2% in Q1 2026, selling an estimated $83.2K and leaving 969,066 shares worth $8.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Franklin Resources first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Franklin Resources held 969,066 shares of Immix Biopharma worth $8.83M as of Q1 2026.
  • Franklin Resources sold 11,326 Immix Biopharma shares in Q1 2026, an estimated $83.2K.
  • Immix Biopharma made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1286 holding.
  • Franklin Resources first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.